Vazkepa
·
- Prescription status not stated
- Heart, blood pressure and circulation
- Active substance
- Icosapent ethyl
- Made by
- Recordati Industria Chimica e Farmaceutica S.p.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Indicated to reduce cardiovascular risk as an adjunct to statin therapy.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | Recordati Industria Chimica e Farmaceutica S.p.A. |
|---|---|
| Active substance | Icosapent ethyl |
| Used in | Heart, blood pressure and circulation |
| Classification | C10AX · Heart, blood pressure and circulation |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2021-03-26 |
| Last updated by the regulator | 2026-03-13 |
| EMA product number | EMEA/H/C/005398 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).